182 related articles for article (PubMed ID: 22251182)
1. Average cost-effectiveness ratio with censored data.
Bang H; Zhao H
J Biopharm Stat; 2012; 22(2):401-15. PubMed ID: 22251182
[TBL] [Abstract][Full Text] [Related]
2. A study on confidence intervals for incremental cost-effectiveness ratios.
Wang H; Zhao H
Biom J; 2008 Aug; 50(4):505-14. PubMed ID: 18663759
[TBL] [Abstract][Full Text] [Related]
3. Uncertainty of incremental cost-effectiveness ratios. A comparison of Fieller and bootstrap confidence intervals.
Severens JL; De Boo TM; Konst EM
Int J Technol Assess Health Care; 1999; 15(3):608-14. PubMed ID: 10874387
[TBL] [Abstract][Full Text] [Related]
4. Estimating incremental cost-effectiveness ratios and their confidence intervals with differentially censored data.
Wang H; Zhao H
Biometrics; 2006 Jun; 62(2):570-5. PubMed ID: 16918922
[TBL] [Abstract][Full Text] [Related]
5. Estimating incremental cost-effectiveness ratios and their confidence intervals with different terminating events for survival time and costs.
Chen S; Zhao H
Biostatistics; 2013 Jul; 14(3):422-32. PubMed ID: 23426525
[TBL] [Abstract][Full Text] [Related]
6. A note on the estimation of confidence intervals for cost-effectiveness when costs and effects are censored.
Blackhouse G; Briggs AH; O'Brien BJ
Med Decis Making; 2002; 22(2):173-7. PubMed ID: 11958499
[TBL] [Abstract][Full Text] [Related]
7. Nonparametric statistical methods for cost-effectiveness analyses.
Dinh P; Zhou XH
Biometrics; 2006 Jun; 62(2):576-88. PubMed ID: 16918923
[TBL] [Abstract][Full Text] [Related]
8. Nonparametric inference for time-dependent incremental cost-effectiveness ratios.
Yee LM; Gary Chan KC
Stat Med; 2015 Dec; 34(30):4057-69. PubMed ID: 26215727
[TBL] [Abstract][Full Text] [Related]
9. Nonparametric inference for median costs with censored data.
Zhao H; Zuo C; Chen S; Bang H
Biometrics; 2012 Sep; 68(3):717-25. PubMed ID: 22364557
[TBL] [Abstract][Full Text] [Related]
10. Bootstrap confidence intervals for medical costs with censored observations.
Jiang H; Zhou XH
Stat Med; 2004 Nov; 23(21):3365-76. PubMed ID: 15490430
[TBL] [Abstract][Full Text] [Related]
11. On estimating medical cost and incremental cost-effectiveness ratios with censored data.
Zhao H; Tian L
Biometrics; 2001 Dec; 57(4):1002-8. PubMed ID: 11764238
[TBL] [Abstract][Full Text] [Related]
12. Trying to do better than average: a commentary on 'statistical inference for cost-effectiveness ratios'.
Briggs A; Fenn P
Health Econ; 1997; 6(5):491-5. PubMed ID: 9353649
[TBL] [Abstract][Full Text] [Related]
13. Confidence intervals for cost-effectiveness ratios: a comparison of four methods.
Polsky D; Glick HA; Willke R; Schulman K
Health Econ; 1997; 6(3):243-52. PubMed ID: 9226142
[TBL] [Abstract][Full Text] [Related]
14. Estimation, power and sample size calculations for stochastic cost and effectiveness analysis.
Walter SD; Gafni A; Birch S
Pharmacoeconomics; 2007; 25(6):455-66. PubMed ID: 17523751
[TBL] [Abstract][Full Text] [Related]
15. Net-benefit regression with censored cost-effectiveness data from randomized or observational studies.
Chen S; Hoch JS
Stat Med; 2022 Sep; 41(20):3958-3974. PubMed ID: 35665527
[TBL] [Abstract][Full Text] [Related]
16. HIQA's CEA of Breast Screening: Pragmatic Policy Recommendations are Welcome, but ACERs Reported as ICERs are Not.
O'Mahony JF; Normand C
Value Health; 2015 Dec; 18(8):941-5. PubMed ID: 26686777
[TBL] [Abstract][Full Text] [Related]
17. Median-based incremental cost-effectiveness ratios with censored data.
Bang H; Zhao H
J Biopharm Stat; 2016; 26(3):552-64. PubMed ID: 26010599
[TBL] [Abstract][Full Text] [Related]
18. On the censored cost-effectiveness analysis using copula information.
Fontaine C; Daurès JP; Landais P
BMC Med Res Methodol; 2017 Feb; 17(1):27. PubMed ID: 28202010
[TBL] [Abstract][Full Text] [Related]
19. Problems with interval estimates of the incremental cost-effectiveness ratio.
Heitjan DF; Moskowitz AJ; Whang W
Med Decis Making; 1999; 19(1):9-15. PubMed ID: 9917015
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness inferences from bootstrap quadrant confidence levels: three degrees of dominance.
Obenchain RL; Robinson RL; Swindle RW
J Biopharm Stat; 2005; 15(3):419-36. PubMed ID: 15920889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
